As reported in the Japanese newspaper, Nikkei, Pfizer, the world’s leading pharmaceutical companies, are considering marketing generic drugs in Japan, starting as early as 2011. A spokesman from Pfizer’s Japan unit stated, “Pfizer is considering entering the generic drug market in Japan as it seeks to diversify its business operations to build a stronger earnings structure.”
The Japanese drug division will initially market 70 of Pfizer’s off-patient medications. Further along the line it is planned that the company will apply for sales licenses for generic drugs based on other companies’ expired patents. This could be a profitable move with Japan’s generic drugs market expected to reach 515 billion yen in the year ended March 2010 and potentially creating many jobs within the pharmaceutical industry. To search for pharmaceutical or clinical jobs click here.